| Reference : WATER-SOLUBLE NIMESULIDE SALT, AND USES THEREOF FOR THE TREATMENT OF INFLAMMATIONS |
| Patent : Patent | |||
| Human health sciences : Pharmacy, pharmacology & toxicology | |||
| http://hdl.handle.net/2268/65771 | |||
| WATER-SOLUBLE NIMESULIDE SALT, AND USES THEREOF FOR THE TREATMENT OF INFLAMMATIONS | |
| English | |
| [fr] SEL DE NIMESULIDE HYDROSOLUBLE ET LEURS UTILISATIONS POUR LE TRAITEMENT DES AFFECTIONS INFLAMMATOIRES | |
Pirotte, Bernard [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >] | |
Piel, Géraldine [Université de Liège - ULg > Département de pharmacie > Pharmacie galénique >] | |
| Delneuville, Isabelle [ > > ] | |
| Neven, Philippe [ > > ] | |
| Geczy, Joszef [ > > ] | |
| 21-Dec-1995 | |
| 1995-12-21 | |
| US patent office | |
| WO/1995/034533 | |
| BE19940000582 19940616 | |
| none | |
| US | |
| Europharmaceuticals s.a. | |
| A61K31/18; A61K31/195; A61K31/198; A61K31/205; A61K31/63; A61K47/40; A61K47/48; A61P29/00; C07C229/26; C07C311/08; C08B37/00; C08B37/16; C08L3/00; C08L3/02;A61K31/18; A61K31/185; A61K31/63; A61K47/40; A61K47/48;A61P29/00; C07C229/00; C07C311/00; C08B37/00; C08L3/00;(IPC1-7): A61K31/63; A61K47/48; C07C229/26; C07C311/08;C08B37/00 | |
| A61K47/48H4; A61K47/48H4C; A61K47/48W18B; C07C229/26; C07C311/08; C08B37/00M2B2; Y01N2/00 | |
| AM, AT, AU, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IS, JP, KE, KG, KP, KR, KZ, LK, LR, LT, LU, LV, MD, MG, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TT, UA, UG, US, UZ, VN. | |
| AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE | |
| [en] Water-soluble nimesulide salt comprised of the product obtained from the reaction of nimesulide and L-lysine, preparation thereof, aqueous solution containing it, associations based on nimesulide with cyclodextrins, and uses thereof. | |
| Researchers ; Professionals | |
| http://hdl.handle.net/2268/65771 |
There is no file associated with this reference.
All documents in ORBi are protected by a user license.